Прободные гастродуоденальные язвы: современные тенденции в лечении

Прободные гастродуоденальные язвы: современные тенденции в лечении

Автор: Тимербулатов Шамиль Вилевич, Тимербулатов М.В., Хисамутдинова Р.И.

Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center

Рубрика: Обзоры литературы

Статья в выпуске: 2 т.12, 2017 года.

Бесплатный доступ

Короткий адрес: https://sciup.org/140188650

IDR: 140188650

Список литературы Прободные гастродуоденальные язвы: современные тенденции в лечении

  • Борисов А.Е. Неотложная хирургия язвенной болезни желудка и двенадцатиперстной кишки./Борисов А.Е., Земляной В.П., Акимов В.П. -С.-Петербург: Человек. 2002.
  • Курбонов K.M. Внедрение эндовидеохирургии при остром животе./Курбонов K.M.//Здравоохранение Таджикистана, 2005. -№ 3. -С. 78-79.
  • Лобанков В.М. Проблемы хирургического лечения язвенной болезни./Лобанков В.М.//Здравоохранение, 2005. -№ 7. -С. 25-29.
  • Шулутко A.M. Прободная пилородуоденальная язва: ушивание или комбинированное хирургическое лечение?/Шулутко A.M., Данилов А.И., Буров К.В.//Рос. Мед. Журн., 2005. -№ 2. -С. 43-46.
  • Mоller M.H. Multicentre trial of a perioperative protocol to reduce mortality in patients with peptic ulcer perforation./Mоller M.H., Adamsen S., Thomsen R.W. et al.//Br. J. Surg., 2011. -98: 802-810.
  • Malfertheiner P. Peptic ulcer disease./Malfertheiner P., Chan F.K., McColl K.E.//Lancet, 2009. -374: 1449-1461.
  • Wang Y.R. Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006./Wang Y.R., Richter J.E., Dempsey D.T.//Ann. Surg, 2010. -251: 51-58.
  • Lau J.Y. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality./Lau J.Y., Sung J., Hill C. et al.//Digestion. -2011. -84: 102-113.
  • Guzel H. Peptic ulcer complications requiring surgery: What has changed in the last 50 years in Turkey./Guzel H., Kahramanca S., Seker D. et al.//Turk. J. Gastroenterol. -2014. -25: 152-155.
  • Hermansson M. Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002./Hermansson M., Ekedahl A., Ranstam J. and Zilling T.//BMC Gastroenterol. -2009. -9: 25.
  • Bashinskaya B. Trends in peptic ulcer disease and the identification of Helicobacter pylori as a causative organism: population-based estimates from the US nationwide inpatient sample./Bashinskaya B., Nahed B.V., Redjal N., Kahle K.T. and Walcott B.P.//J. Glob. Infect. Dis. -2011. -3: 366-370.
  • Lanas A. The changing face of hospitalisation due to gastrointestinal bleeding and perforation./Lanas A., Garcia-Rodriguez L.A., Polo-Tomas M. et al.//Aliment. Pharmacol. Ther. -2011. -33: 585-591.
  • Sonnenberg A. Time trends of ulcer mortality in Europe./Sonnenberg A.//Gastroenterology, -2007. -132: 2320-2327.
  • Thorsen K. Trends in diagnosis and surgical management of patients with perforated peptic ulcer./Thorsen K., Glomsaker T.B., von Meer A., Søreide K. and Søreide J.A.//J. Gastrointest. Surg. -2011. -15: 1329-1335.
  • Thorsen K. Gastro-duodenal peptic ulcer perforation./Thorsen K., Glomsaker T.B., von Meer A., Søreide K. and Søreide J.A.//East Afr. Med. J. -2009. -86: 100-109.
  • Surapaneni S. The perforation-operation time interval; an important mortality indicator in peptic ulcer perforation./Surapaneni S., S. R., and Reddy A.V.B.//J. Clin. Diagn. Res. -2013. -7: 880-882.
  • Horowitz J. All perforated ulcers are not alike./Horowitz J., Kukora J.S., and Ritchie W.P. Jr.//Ann. Surg. -1989. -209: 693-696.
  • Salama N.R. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori./Salama N.R., Hartung M.L., and Müller A//Nat. Rev. Microbiol. -2013. -11: 385-399.
  • Cid T.P. Pathogenesis of Helicobacter pylori infection./Cid T.P., Fernandez M.C., Benito Martinez S., and Jones N.L.//Helicobacter. -2013. -18: 12-17.
  • Svanes C. Smoking and ulcer perforation./Svanes C., Søreide J.A., Skarstein A. et al.//Gut. -1997. -41: 177-180.
  • Guerra J.B. IL-1 gene cluster and TNFA-307 polymorphisms in the risk of perforated duodenal ulcer./Guerra J.B., Rocha G.A., Rocha A.M. et al.//Gut. -2006. -55: 132-133.
  • Wong B.P. Complications of peptic ulcer disease in children and adolescents: minimally invasive treatments offer feasible surgical options./Wong B.P., Chao N.S., Leung M.W., Chung K.W., Kwok W.K., and Liu K.K.//J. Pediatr. Surg. -2006. -41: 2073-2075.
  • Lanas A. Evidence of aspirin use in both upper and lower gastrointestinal perforation./Lanas A., Serrano P., Bajador E., Esteva F., Benito R., and Sáinz R.//Gastroenterology. -1997. -112: 683-689.
  • Ishikawa S. Characteristics of serious complicated gastroduodenal ulcers in Japan./Ishikawa S., Inaba T., Mizuno M. et al.//Hepatogastroenterology. -2012. -59: 147-154.
  • Gökakin A.K. The impact of Ramadan on peptic ulcer perforation./Gökakin A.K., Kurt A., Atabey M. et al.//Ulus Travma Acil. Cerrahi. Derg. -2012. -18: 339-343.
  • Wendling M.R. Omental patch repair effectively treats perforated marginal ulcer following Roux-en-Y gastric bypass./Wendling M.R., Linn J.G., Keplinger K.M. et al.//Surg. Endosc. -2013. -27: 384-389.
  • Cheng C.L. Acute pyloric perforation after prolonged crack smoking./Cheng C.L. and Svesko V.//Ann. Emerg. Med. -1994. -23: 126-128.
  • Jones H.G. A perforated duodenal ulcer presenting as inferior lead ST elevation following amphetamine use./Jones H.G., Hopkins L., Clayton A., and McKain E.//Ann. R. Coll. Surg. Engl. -2012. -94: e144-e145.
  • Hirschowitz B.I. Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study./Hirschowitz B.I., Simmons J., and Mohnen J.//Clin. Gastroenterol. Hepatol. -2005. -3: 39-48.
  • Buck D.L. Surgical delay is a critical determinant of survival in perforated peptic ulcer./Buck D.L., Vester-Andersen M., Møller M.H., and the Danish Clinical Register of Emergency Surgery//Br. J. Surg. -2013. -100: 1045-1049.
  • Møller M.H. Preoperative prognostic factors for mortality in peptic ulcer perforation: a systematic review./Møller M.H., Adamsen S., Thomsen R.W., and Møller A.M.//Scand. J. Gastroenterol. -2010. -45: 785-805.
  • Thorsen K. Scoring systems for outcome prediction in patients with perforated peptic ulcer./Thorsen K., Søreide J.A., and Søreide K.//Scand. J. Trauma Resusc. Emerg. Med. -2013. -21: 25.
  • Thorsen K. What is the best predictor of mortality in perforated peptic ulcer disease? A population-based, multivariable regression analysis including three clinical scoring systems./Thorsen K., Søreide J.A., and Søreide K.//J. Gastrointest. Surg. -2014. -18: 1261-1268.
  • Boey J. Risk stratification in perforated duodenal ulcers. A prospective validation of predictive factors./Boey J., Choi S.K., Poon A., and Alagaratnam T.T.//Ann. Surg. -1987. -205: 22-26.
  • Buck D.L. Accuracy of clinical prediction rules in peptic ulcer perforation: an observational study./Buck, D.L., Vester-Andersen M., and Møller M.H.//Scand. J. Gastroenterol. -2012. -47: 28-35.
  • Søreide K. Strategies to improve the outcome of emergency surgery for perforated peptic ulcer./Søreide K., Thorsen K., and Søreide J.A.//Br. J. Surg. -2014. -101: e51-e64.
  • Crofts T.J. A randomized trial of nonoperative treatment for perforated peptic ulcer./Crofts T.J., Park K.G., Steele R.J., Chung S.S., and Li A.K.//N. Engl. J. Med. -1989. -320: 970-973.
  • Donovan A.J. Perforated duodenal ulcer: an alternative therapeutic plan./Donovan A.J., Berne T.V., and Donovan J.A.//Arch. Surg. -1998. -133: 1166-1171.
  • Cao F. Nonoperative management for perforated peptic ulcer: who can benefit?/Cao F., Li J., Li A., Fang Y., Wang Y.J., and Li F.//Asian J. Surg. -2014. -37: 148-153.
  • Sanabria A. Laparoscopic repair for perforated peptic ulcer disease./Sanabria A., Villegas M.I., and Morales Uribe C.H.//Cochrane Database Syst. Rev. -2013. -2 (CD004778).
  • Wong C.S. Eradication of Helicobacter pylori for prevention of ulcer recurrence after simple closure of perforated peptic ulcer: a meta-analysis of randomized controlled trials./Wong C.S., Chia C.F., Lee H.C. et al.//J. Surg. Res. -2013. -182: 219-226.
  • Ergul E. Emergency spontaneous gastric perforations: ulcus versus cancer./Ergul E. and Gozetlik E.O.//Langenbecks Arch. Surg. -2009. -394: 643-646.
  • Taylor H. Perforated peptic ulcer; treated without operation./Taylor H.//Lancet. -1946. -2: 441-444.
  • Wilhelmsen M. Surgical complications after open and laparoscopic surgery for perforated peptic ulcer in a nationwide cohort./Wilhelmsen M., Møller M.H., and Rosenstock S.//Br. J. Surg. -2015. -102: 382-387.
  • Wright G.P. Cost-efficiency and outcomes in the treatment of perforated peptic ulcer disease: laparoscopic versus open approach./Wright G.P., Davis A.T., Koehler T.J., and Scheeres D.E.//Surgery. -2014. -156: 1003-1007.
  • Antoniou S.A. Meta-analysis of laparoscopic versus open repair of perforated peptic ulcer./Antoniou S.A., Antoniou G.A., Koch O.O., Pointner R., and Granderath F.A.//JSLS. -2013. -17: 15-22.
  • Bertleff M.J. Laparoscopic correction of perforated peptic ulcer: first choice? A review of literature./Bertleff M.J. and Lange J.F.//Surg. Endosc. -2010. -24: 1231-1239.
  • Kumar P. Treatment of perforated giant gastric ulcer in an emergency setting./Kumar P., Khan H.M., and Hasanrabba S.//World J. Gastrointest. Surg. -2014. -6: 5-8.
  • Gupta V. Study on the use of T-tube for patients with persistent duodenal fistula: is it useful?/Gupta V., Singh S.P., Pandey A., and Verma R.//World J. Surg. -2013. -37: 2542-2545.
  • Tanaka R. Treatment for perforated gastric ulcer: a multi-institutional retrospective review./Tanaka R., Kosugi S., Sakamoto K. et al.//J. Gastrointest. Surg. -2013. -17: 2074-2081.
  • Parodi A. Endoscopic management of GI perforations with a new over-the-scope clip device (with videos)./Parodi A., Repici A., Pedroni A., Blanchi S., and Conio M.//Gastrointest. Endosc. -2010. -72: 881-886.
  • Mönkemüller K. Multipurpose use of the 'bear claw’ (over-the-scope-clip system) to treat endoluminal gastrointestinal disorders./Mönkemüller K., Peter S., Toshniwal J. et al.//Dig. Endosc. -2014. -26: 350-357.
  • Bertleff M.J. Comparison of closure of gastric perforation ulcers with biodegradable lactide-glycolide-caprolactone or omental patches./Bertleff M.J., Stegmann T., Liem R.S. et al.//JSLS. -2009. -13: 550-554.
  • Liu L. Effect of local injection of mesenchymal stem cells on healing of sutured gastric perforation in an experimental model./Liu L., Chiu P.W., Lam P.K. et al.//Br. J. Surg. -2015. -102: e158-e168.
  • Soreide K. Perforated peptic ulcer./Soreide K., Thorsen K., Harrison E.M.//Lancet. 2015. -386: 1288-1298.
Еще
Статья
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp